Description
Doctors may prescribe Erlocip 150 mg for patients with advanced-stage non-small cell lung cancer (NSCLC). It also works to slow or stop the growth of cancer cells in the pancreas. It contains the active ingredient Erlotinib, which works by preventing the activity of a protein called epidermal growth factor receptor (EGFR). This is the protein responsible for the growth and spread of cancer cells. Your doctor may also prescribe Erlocip to you in combination with another treatment called gemcitabine if you have pancreatic cancer at a metastatic stage. You may also receive the anticancer drug if previous chemotherapy has not helped to stop your disease.


















Reviews
There are no reviews yet.